Adjuvant gefitinib versus cisplatin/vinorelbine in Japanese patients with completely resected, EGFR-mutated, stage II-III non-small cell lung cancer (IMPACT, WJOG6410L): A randomized phase 3 trial.Hirohito Tada, Tetsuya Mitsudomi, Takeharu Yamanaka et al.|Journal of Clinical Oncology|2021Cited by 24